Abstract:Wenjing Hou, 1, 2, &ast Jiayu Yang, 3, &ast Kuifen Ma, 2, 4 Xiangduan Liu, 2, 5 Hui Yang, 2, 6 Qing Qian, 2, 7 Pan Chen, 2, 8 Fang Zeng, 2, 9 Rongrong Wang, 2, 4 Guangzhao Wang, 2, 10 Aiping Wen 1 1 Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, People's Republic of China; 2 National Alliance of Transplant Pharmacists, Zhejiang, People's Republic of China; 3 Department of Pharmacy, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, People's Republic of China; 4 Department of Clinical Pharmacy, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 311500, People's Republic of China; 5 Department of Pharmacy, Fifth Clinical College of Henan University of Traditional Chinese Medicine (Zhengzhou People's Hospital), Zhengzhou, 450000, People's Republic of China; 6 Department of Pharmacy, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, 100020, People's Republic of China; 7 Department of Pharmacy, The First People's Hospital of Changzhou, Changzhou, Jiangsu, 213003, People's Republic of China; 8 Department of Pharmacy, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510080, People's Republic of China; 9 Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People's Republic of China; 10 Department of Pharmacy, The First People's Hospital of Yulin, Yulin, Guangxi, 537000, People's Republic of China &astThese authors contributed equally to this work Correspondence: Aiping Wen, Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University, 95&num Yongan Street, Beijing, 100050, People's Republic of China, Email Background: Current guidelines support routine perioperative antibiotic prophylaxis (PAP) to minimize surgical site infection in kidney transplantation (KT), though data regarding the current practices of PAP is lacking in China. Objective: To survey the routine PAP strategies in KT, and analyze main clinical considerations associated with adjusted antibiotic dosing regimens in different Chinese hospitals. Methods: A nationwide survey was conducted on behalf of the National Alliance of Transplant Pharmacists. An online questionnaire was created via Wen Juan Xing ( http://www.wjx.cn ) and sent to all pharmacists in the Alliance. Results: Twenty-three pharmacists from different teaching hospitals with Grade IIIA participated in the survey, with a response rate of 46.0%. There were wide differences in routine dosing regimens and clinical considerations. Six strategies were involved in living-donor KT and monotherapy was most often used (80.9%), while combination therapy was most common (69.6%) among the ten strategies in deceased-donor KT. Of fifteen antibiotics submitted in the survey, eight agents were prescribed with different doses and/or frequencies among different hospitals. Only 37.5% and 23.1% of the hospitals would stop PAP within 72 hours in living-donor KT and deceased-donor KT, respectively. Among 28 preset factors, four factors were considered significantly important to decide PAP regimens, and eight factors were considered significantly unimportant (P< 0.05). Conclusion: There was wide variability in routine dosing regimens and clinical considerations in PAP decisions in KT. Further investigations are warranted to obtain high-quality evidence and to make PAP in KT more rational. Keywords: perioperative antibiotic prophylaxis, clinical consideration, kidney transplant, nationwide survey Solid-organ transplantation is the best therapeutic option for patients with end-stage organ disease. The rate of surgical site infection (SSI) was the lowest (3.0%~11.0%) in kidney transplant recipients (KTRs) among all the organ transplant types. 1,2 However, it is also crucial to carry out perioperative infection prevention to minimize the risk of SSIs because SSIs are associated with prolonged hospitalization and reduced graft survival. 3 There are some guidelines on perioperative antibiotic prophylaxis (PAP) in kidney transplantation (KT), though specific recommendations are inconsistent: 1,2,4–7 (1) first-generation cephalosporin for 24 hours or less, 2,4,7 (2) first- or second-generation cephalosporins or penicillins with beta-lactams (BLs) for single dose or within 72 hours, 6 (3) first- o -Abstract Truncated-

Survey on the approach to antibiotic prophylaxis in liver and kidney transplant recipients colonized with "difficult to treat" Gram‐negative bacteria

Active Surveillance of Carbapenem-Resistant Gram-Negative Bacteria to Guide Antibiotic Therapy: a Single-Center Prospective Observational Study

Screening for tropical and imported infections in migrant kidney transplant candidates from the kidney transplant access consultation

Epidemiology and Prevention of Early Infections by Multi-Drug-Resistant Organisms in Adults Undergoing Liver Transplant: A Narrative Review

Molecular Epidemiology, Natural History, and Long-Term Outcomes of Multidrug-Resistant Enterobacterales Colonization and Infections among Solid Organ Transplant Recipients

Initial empirical antibiotic therapy in kidney transplant recipients with pyelonephritis: A global survey of current practice and opinions across 19 countries on six continents

New Antibiotics Against Multidrug-Resistant Gram-Negative Bacteria in Liver Transplantation: Clinical Perspectives, Toxicity, and PK/PD Properties

Multi-drug resistant and extended spectrum beta-lactamase Gram-negative bacteria in bilateral lung transplant recipients. Incidence, risk factors and in-hospital mortality.

2111. Impact of Colonization by Multi Drug Resistant Bacteria on Graft Survival, Risk of Infection, and Mortality in Recipients of Solid Organ Transplant: Systematic Review and Meta-analysis

Assessment of Current Practices for Perioperative Antibiotic Prophylaxis in Kidney Transplantation in China: Results from a Nationwide Survey

Distribution and Antibiotic Susceptibility Pattern of Multidrug-Resistant Bacteria and Risk Factors Among Kidney Transplantation Recipients with Infections Over 13 Years: A Retrospective Study

Perceived Differences Between Intensivists and Infectious Diseases Consultants Facing Antimicrobial Resistance: a Global Cross-Sectional Survey

Effectiveness of surveillance cultures for high priority multidrug-resistant bacteria in hematopoietic stem cell transplant units

Assessment of Posttransplant Bacteremia Caused by Extended-Spectrum Beta-Lactamase-Producing Gram-Negative Bacteria Among Kidney Transplant Recipients

The Burden and Impact of Early Post-Transplant Multidrug-resistant Organism Detection Among Renal Transplant Recipients, 2005-2021

The Impact of Colonization by Multi Drug Resistant Bacteria on Graft Survival, Risk of Infection, and Mortality in Recipients of Solid Organ Transplant: Systematic Review and Meta-analysis

Optimal Perioperative Antimicrobial Management Strategies of Kidney Transplant Recipients Guided by Metagenomic Next-Generation Sequencing of Deceased Donors' Microbiology Samples

Multidrug-resistant bacterial infections after liver transplantation: prevalence, impact, and risk factors

Carbapenems versus Cephalosporin or Piperacillin-Tazobactam as Perioperative Antibiotic Prophylaxis in Liver Transplant Recipients with Model for End-Stage Liver Disease Scores of >= 30: A Retrospective Study in a Chinese Population

National Survey and consensus document on dosing strategies for beta-lactam antibiotics against multidrug-resistant gram-negative bacilli (MDR-GNB) in critically ill patients undergoing extracorporeal life support techniques: The DOSEBL study protocol

Assessing the quality of antimicrobial prescribing in solid organ transplant recipients: a new frontier in antimicrobial stewardship